![]() |
|||||||||||||||||||||||||||
Prostate cancer screening in
|
|||||||||||||||||||||||||||
|
Age Range |
Median PSA level (HIV-) |
Median PSA level (HIV+) |
p-value* |
| 40–49 |
0.71 (n*=48) |
0.54 (n=52) |
0.03 |
| 50–59 |
0.96 (n=87) |
0.68 (n=76) |
0.0002 |
| 60–69 |
1.5 (n=44) |
1.33 (n=24) |
0.66 |
| Over 70 |
1.86 (n=47) |
(n=0) |
- |
|
n = the number
of men included in the age range and HIV grouping. |
|||
This study is important as it is estimated that about 14% of HIV-positive African American men are over the age of forty and should be undergoing age-appropriate screening for prostate cancer. Doctors should be aware that African American men living with HIV may have lower PSA levels compared to their HIV-negative counterparts and be aware that this may make early detection of prostate cancer by relying on PSA more difficult. It is likely that this information also applies to men of different races and ethnicities.
© 2008 Project Inform 1375 Mission
Street, San Francisco, CA 94103 415-558-8669
National HIV/AIDS Treatment Hotline 1-800-822-7422 (415-558-9051 local/int'l) 10a-4p Mon-Fri PST